Could a simple supplement shield dialysis Kids' hearts?
NCT ID NCT06286098
First seen Mar 09, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tests whether a daily dose of alpha lipoic acid, an antioxidant, can lower the risk of heart problems in 50 children who are on regular hemodialysis. Participants will either take the supplement or a placebo pill and be monitored for heart events like stroke or angina. The goal is to see if the supplement reduces oxidative stress and improves heart health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New Pediatrics Hospital, Faculty of Medicine, Ain Shams University
Cairo, El Weili, 11381, Egypt
Conditions
Explore the condition pages connected to this study.